sodium fluoride and Bowel Diseases, Inflammatory studies

sodium fluoride and Bowel Diseases, Inflammatory

Research Excerpts

Excerpt	Relevance	Reference
"Osteoporosis is a frequent complication in the course of various gastrointestinal disorders."	2.42	Management of osteoporosis in patients with gastrointestinal diseases. ( Reinshagen, M; von Tirpitz, C, 2003)
"Osteoporosis is a frequent complication in patients with inflammatory bowel disease."	1.35	Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model. ( Klaus, J; König, HH; Konnopka, A; Kreck, S; Leidl, R; Matschinger, H; von Tirpitz, C, 2008)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

3 (100.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
von Tirpitz, C	2
Reinshagen, M	1
Kreck, S	1
Klaus, J	1
Leidl, R	1
Konnopka, A	1
Matschinger, H	1
König, HH	1
Lin, CL	1
Moniz, C	1
Chow, JW	1

Studies

von Tirpitz, C

Reinshagen, M

Kreck, S

Klaus, J

Leidl, R

Konnopka, A

Matschinger, H

König, HH

Lin, CL

Moniz, C

Chow, JW

Reviews

1 review available for sodium fluoride and Bowel Diseases, Inflammatory

Article	Year
Management of osteoporosis in patients with gastrointestinal diseases. European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:8 Topics: Bone and Bones; Calcitonin; Calcium; Celiac Disease; Dietary Supplements; Diphosphonates; Female; Ga	2003

Article

Year

Management of osteoporosis in patients with gastrointestinal diseases.

European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:8

Topics: Bone and Bones; Calcitonin; Calcium; Celiac Disease; Dietary Supplements; Diphosphonates; Female; Ga

2003

Other Studies

2 other studies available for sodium fluoride and Bowel Diseases, Inflammatory

Article	Year
Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model. PharmacoEconomics, 2008, Volume: 26, Issue:4 Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Calcium; Cholecalciferol; Cost-Benefit	2008
Treatment with fluoride or bisphosphonates prevents bone loss associated with colitis in the rat. Calcified tissue international, 2000, Volume: 67, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Colitis; Diphosphonates; Disease Models, Animal; Inflammatory Bow	2000

Article

Year

Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.

PharmacoEconomics, 2008, Volume: 26, Issue:4

Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Calcium; Cholecalciferol; Cost-Benefit

2008

Treatment with fluoride or bisphosphonates prevents bone loss associated with colitis in the rat.

Calcified tissue international, 2000, Volume: 67, Issue:5

Topics: Animals; Anti-Inflammatory Agents; Colitis; Diphosphonates; Disease Models, Animal; Inflammatory Bow

2000